Kathryn Boger, Ph.D., said leaving academic medicine to co-found InStride Health was both terrifying and transformative. Boger reflected on advice she received early and said, “If you’re feeling scared, it’s a sign that you’re growing.” This wisdom continues to shape her path today.
Kathryn Boger, Ph.D., co-founder and chief clinical officer of InStride Health, is one of this year’s Managed Healthcare Executive Emerging Leaders in Healthcare.
In a recent video interview, she shared insights on the turning point that shaped her career, the one thing she would change about U.S. healthcare and a personal goal she’s striving for outside of work.
A pivotal moment in Boger’s career came when she decided to leave academic medicine—a field she believed she’d remain in long-term. After spending her postdoctoral and professional years at McLean Hospital, she took the leap to launch InStride Health.
“It was a risky one and really rewarding,” Boger said. “The pace and the rapid change is like nothing I had experienced before.”
She credits advice from her brother-in-law for helping her face her fears: “If you're feeling scared, it's a sign that you're growing.”
When asked what she would change about U.S. healthcare, Boger said she would ensure access to evidence-based mental health care for all families, regardless of income, location or background.
“At this point, there are just too many families who are going untreated or who aren’t getting the right treatments,” she said.
Reflecting on her previous role at McLean, Boger would get phone calls daily from families in need because their children were struggling and they weren't able to access the right care.
"So (we're) highly motivated to work on solving that problem," she added.
Her passion to expand access was a driving force behind co-founding InStride.
“That’s really the reason that we built InStride, was to provide access to care that is both evidence-based and insurance-backed,” she said.
Outside of her professional role, Boger is focused on a simple goal: being present.
A childhood memory of running laps with her cousin—earning sticks as somewhat of a prize—reminds her how much joy exists in the moment.
“I want to be able to appreciate the ride I’m on,” she said, “as opposed to just focus on the destination.”
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Report: Cyberattacks Have Impacted Patient Care, Nearly 20% of Healthcare Leaders Say
June 5th 2025Although 52% of healthcare leaders believe a fatal cyber-related patient incident will happen within the next five years, cybersecurity was not ranked as a top business challenge, according to the results of Omega Systems’ 2025 Healthcare IT Landscape Report.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Kathryn Boger, Ph.D. | 2025 MHE Emerging Leaders in Healthcare
June 5th 2025Co-founder and chief clinical officer, InStride Health. InStride Health provides evidence-based care for children, teens and young adults with anxiety and obsessive-compulsive disorder (OCD) and their families.
Read More
FDA Approved Bayer’s Nubeqa for Metastatic Castration-Sensitive Prostate Cancer
June 5th 2025The approval is based on results from the phase 3 ARANOTE trial, which showed Nubeqa, when combined with androgen deprivation therapy (ADT), reduced the risk of radiographic progression or death by 46% compared to ADT with placebo.
Read More